NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.58% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.29% |
| ROIV | Roivant Sciences Ltd | Healthcare | Biotechnology | 1.20% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 1.12% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 1.08% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.05% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 1.00% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 0.98% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 0.98% |
| CGON | CG Oncology, Inc. Common stock | Healthcare | Biotechnology | 0.96% |
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 0.94% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 0.94% |
| CELC | Celcuity LLC | Healthcare | Biotechnology | 0.93% |
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 0.93% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 0.92% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 0.92% |
| MTSR | Metsera, Inc. Common Stock | Healthcare | Biotechnology | 0.91% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 0.91% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 0.88% |